Deguan Lv

2.0k citations
25 papers · 1.1k indexed · h-index 18
Topics
Apelin-related biomedical research (11 papers)Nuclear Receptors and Signaling (10 papers)Cardiovascular, Neuropeptides, and Oxidative Stress Research (9 papers)
Partner nations
ChinaUnited StatesMexico

In The Last Decade

Deguan Lv

25 papers receiving 1.1k citations

Peers

Deguan Lv
Comparison fields: 5 of 82
  • Molecular Biology 561
  • Pharmacology 344
  • Surgery 306
  • Cancer Research 265
  • Cellular and Molecular Neuroscience 225
Replace Yujung Kang with:
Yujung Kang South Korea
Curran Murphy United States
Junfang Zheng China
Sripriya Ranganathan United States
Alicia Zukas United States
Lindsay Angus Netherlands
Janet K. Lighthouse United States
Yung‐Wu Chen United States
Sui‐Bing Miao China
Linda Robinson United States
Deguan Lv relative to Yujung Kang South Korea Yujung Kang's profile →
Citations per field
00.5×4.3×
Yujung Kang · 1×
Citations per year

Countries citing papers authored by Deguan Lv

Since Specialization
Citations

This map shows the geographic impact of Deguan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deguan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deguan Lv more than expected).

Fields of papers citing papers by Deguan Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deguan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deguan Lv. The network helps show where Deguan Lv may publish in the future.

Co-authorship network of co-authors of Deguan Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Deguan Lv. A scholar is included among the top collaborators of Deguan Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deguan Lv. Deguan Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 36
3 1
4 19
5 54
6 9
7 121
8 5
9 5
10 47
11 105
12 90
13 103
14 17
15 55
16 28
17 26
18 67
19 60
20 58

About Deguan Lv

Deguan Lv is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Cancer Research, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Apelin-related biomedical research (11 papers), Nuclear Receptors and Signaling (10 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (9 papers). The work is most often cited by research in Pharmacology (344 citations), Cancer Research (265 citations) and Cellular and Molecular Neuroscience (225 citations). Deguan Lv has collaborated with scholars based in China, United States and Mexico. Frequent co-authors include Linxi Chen, Yanxin Li, Weiwei Zhang, Haizhong Feng, Lanfang Li, Jianming Tang, Youzhou Sang, Angel A. Alvarez, Bo Hu and Linxi Chen. Their work appears in journals such as Nature Communications, Molecular Cell and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026